Nanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections. (Q38628767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

title

Nanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Jaywon Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

Nam-Joon Cho

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

publication date

9 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1133-1139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

The emerging nanomedicine landscape

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

The big picture on nanomedicine: the state of investigational and approved nanomedicine products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Emerging viral diseases: confronting threats with new technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Nanomedicine in the Management of Microbial Infection - Overview and Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Virus entry: molecular mechanisms and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Driving a wedge between viral lipids blocks infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Modification of intracellular membrane structures for virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

More than one door - Budding of enveloped viruses through cellular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Virus inhibition induced by polyvalent nanoparticles of different sizes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Size dependence of steric shielding and multivalency effects for globular binding inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

A broad-spectrum antiviral targeting entry of enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Mechanism of an amphipathic alpha-helical peptide's antiviral activity involves size-dependent virus particle lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

A virocidal amphipathic -helical peptide that inhibits hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

HSV neutralization by the microbicidal candidate C5A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Correlation between Membrane Partitioning and Functional Activity in a Single Lipid Vesicle Assay Establishes Design Guidelines for Antiviral Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Rupture of lipid vesicles by a broad-spectrum antiviral peptide: influence of vesicle size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Sustained Local Delivery of Structurally Diverse HIV-1 Microbicides Released from Sublimation Enthalpy Controlled Matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Glycerol monolaurate prevents mucosal SIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Virus capture and destruction by label-free graphene oxide for detection and disinfection applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Mode of antiviral action of silver nanoparticles against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Silver nanoparticles as potential antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Bactericidal and virucidal ultrathin films assembled layer by layer from polycationic N-alkylated polyethylenimines and polyanions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Inhibition of HIV fusion with multivalent gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

Lessons from 60 years of pharmaceutical innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SMLL.201500854

21 January 2018

Identifiers

DOI

10.1002/SMLL.201500854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551316 AND SRC:MED&resulttype=core&format=json

29 February 2020

1 reference